Keyword: rare diseases


Amgen Boosts Rare Diseases with Horizon Buy

15.12.2022 -

Amgen has agreed to buy Horizon Therapeutics for $28.3 billion including debt, boosting its portfolio of drugs for rare autoimmune and inflammatory diseases and beating...


Evotec Enhances Rare Disease Focus with Central Glass Buy

30.08.2022 -

German CDMO Evotec is to acquire compatriot company Central Glass Germany from Japanese owner Central Glass for a nominal price of €1. The transaction, which remains...


Mallinckrodt to buy Sucampo Pharmaceuticals

05.01.2018 - Specialty pharmaceuticals manufacturer Mallinckrodt has agreed to buy biopharmaceuticals producer Sucampo, including its commercial and development assets. The transaction is...


Ergomed Buys Dutch-based PSR Group

05.10.2017 - UK pharmaceutical company Ergomed has acquired PSR Group, a Dutch contract research organization (CRO) that specializes in orphan drug development and is regarded as a leading...


US Law Firm Probes Dr. Reddy’s and PTC

02.03.2016 - US law firm Zeldes Haeggquist & Eck has started investigating a possible violation of federal securities laws by Indian generics manufacturer Dr. Reddy’s Laboratories and US...


GSK Outlines Pipeline for Next 10 Years

06.11.2015 - GlaxoSmithKline (GSK) is expecting to file 20 new drugs by 2020, with another 20 to follow in the following five years. In a presentation to investors in New York, CEO Andrew Witty...


Roche's $8 billion InterMune Buy Not a Sign of More Big Deals

19.09.2014 - The decision by Swiss drugmaker Roche in August to buy US biotech company InterMune for $8.3 billion was "exceptional" and not a sign of more ambitious plans for major acquisitions...


Orphan drugmaker ViroPharma attracts takeover interest

18.06.2013 - ViroPharma is attracting preliminary interest from several pharmaceutical companies about buying the orphan drugmaker, according to three people familiar with the matter. While...